GLP1

SOUTH SAN FRANCISCO, Calif., June 01, 2023 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational treatments for patients with serious metabolic disease marked by high unmet…

<!-- Name:DistributionId Value:8846943 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value:4570 -->…

Using GLP-1s drug injections for weight loss has become one of the latest ways some big names in the market are shedding extra pounds. Elon Musk recently tweeted about how using Novo Nordisk's Wegovy helped him lose weight. Fanatics CEO…

A certain class of antidiabetic agent was linked with gallbladder and biliary diseases, researchers reported. According to a systematic review and…

Access to a certain class of diabetes agents might not be equitable across all patients, a retrospective study suggested. Among over 1 million…

Examples of medications in this group are canagliflozin, dapagliflozin, and empagliflozin. Exenatide, liraglutide, lixisenatide are some examples of this class of drugs. ‘People under six months of continuous antidiabetic therapy using…

An investigational glucagon-like peptide-1 (GLP-1) receptor agonist had significant heart and kidney benefits in an already compromised population with diabetes, the AMPLITUDE-O…

GLP-1 receptor agonist treatment in men with type 2 diabetes may thwart some new cases of erectile dysfunction, an exploratory analysis of a…

The FDA issued new draft guidance regarding early studies on medical devices for type 2 diabetes, accepting online comments through July 20.…

Denmark-headquartered global healthcare major Novo Nordisk and a leading player in the diabetes market, plans to launch this oral GLP-1 drug in India by February 2022. It is billed as an oral drug that promises to not just help diabetes…